Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2686 AL 2700

Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms

Ullah I, Wang X, Li H.

Neurol Sci. 2024 Jul;45(7):2979-2995. doi: 10.1007/s10072-023-07278-7. Epub 2024 Feb 23.

Diverse Functions of Parkin in Midbrain Dopaminergic Neurons

Song P, Krainc D.

Mov Disord. 2024 Aug;39(8):1282-1288. doi: 10.1002/mds.29890. Epub 2024 Jun 10.

Advancements in understanding substantia nigra hyperechogenicity via transcranial sonography in Parkinson's disease and its clinical implications

Zhang YY, Jiang XH, Zhu PP, Zhuo WY, Liu LB.

Front Neurol. 2024 Jul 18;15:1407860. doi: 10.3389/fneur.2024.1407860. eCollection 2024.

[Dementia with Lewy bodies: old and new knowledge-Part 2: treatment]

Dodel R, Berg D, Duning T, Kalbe E, Meyer PT, Ramirez A, Storch A, Aarsland D, Jessen F.

Nervenarzt. 2024 Apr;95(4):362-367. doi: 10.1007/s00115-023-01577-2. Epub 2023 Dec 14.

Protein Translation in the Pathogenesis of Parkinson's Disease

Ashraf D, Khan MR, Dawson TM, Dawson VL.

Int J Mol Sci. 2024 Feb 18;25(4):2393. doi: 10.3390/ijms25042393.

Aggregation and phase separation of α-synuclein in Parkinson's disease

Han W, Wei M, Xu F, Niu Z.

Chem Commun (Camb). 2024 Jun 25;60(52):6581-6590. doi: 10.1039/d4cc01591f.

Current Progress in Magnetic Resonance-Guided Focused Ultrasound to Facilitate Drug Delivery across the Blood-Brain Barrier

Meng Y, Kalia LV, Kalia SK, Hamani C, Huang Y, Hynynen K, Lipsman N, Davidson B.

Pharmaceutics. 2024 May 27;16(6):719. doi: 10.3390/pharmaceutics16060719.

Pesticides and the Gut Microbiota: Implications for Parkinson's Disease

Ghosh N, Sinha K, Sil PC.

Chem Res Toxicol. 2024 Jul 15;37(7):1071-1085. doi: 10.1021/acs.chemrestox.4c00057. Epub 2024 Jul 3.

Neuroprotective Effect of Natural Indole and β-carboline Alkaloids against Parkinson's Disease: An Overview

Shome A, Chahat, Chawla V, Chawla PA.

Curr Med Chem. 2024;31(38):6251-6271. doi: 10.2174/0929867331666230913100624.

Deep Learning for hand tracking in Parkinson's Disease video-based assessment: Current and future perspectives

Amprimo G, Masi G, Olmo G, Ferraris C.

Artif Intell Med. 2024 Aug;154:102914. doi: 10.1016/j.artmed.2024.102914. Epub 2024 Jun 17.

Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review

Kettunen P, Koistinaho J, Rolova T.

J Neuroinflammation. 2024 Jun 6;21(1):152. doi: 10.1186/s12974-024-03139-y.

Unveiling the Journey from the Gut to the Brain: Decoding Neurodegeneration-Gut Connection in Parkinson's Disease

Bhardwaj K, Singh AA, Kumar H.

ACS Chem Neurosci. 2024 Jul 3;15(13):2454-2469. doi: 10.1021/acschemneuro.4c00293. Epub 2024 Jun 19.

Digital biomarkers for precision diagnosis and monitoring in Parkinson's disease

Sun YM, Wang ZY, Liang YY, Hao CW, Shi CH.

NPJ Digit Med. 2024 Aug 21;7(1):218. doi: 10.1038/s41746-024-01217-2.

The Neuroprotective Role of A2A Adenosine Purinoceptor Modulation as a Strategy Against Glioblastoma

Simões JLB, Braga GC, Fontana M, Assmann CE, Bagatini MD.

Brain Sci. 2024 Dec 21;14(12):1286. doi: 10.3390/brainsci14121286.

Metformin role in Parkinson's disease: a double-sword effect

Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Ashour NA, Jabir MS, Negm WA, Batiha GE.

Mol Cell Biochem. 2024 Apr;479(4):975-991. doi: 10.1007/s11010-023-04771-7. Epub 2023 Jun 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias